The increased prevalence of neuropathogenic strains of EHV-1 in equine abortions

Veterinary Microbiology

Volumn 141, Issue 1-2, 2010, Pages 5-11

  Smith, Kathryn L ^a   Allen, George P ^a   Branscum, Adam J ^b   Frank Cook, R ^a   Vickers, Mary L ^b   Timoney, Peter J ^a   Balasuriya, Udeni B R ^a  

^a UNIVERSITY OF KENTUCKY   (United States)

^b UNIVERSITY OF KENTUCKY   (United States)

Author keywords

Equine herpesvirus 1; Equine myeloencephalopathy; Horse; Neuropathogenic EHV 1

Indexed keywords

ADENINE; CYTOSINE; GUANINE; HERPES VACCINE; LIVE VACCINE; NUCLEOTIDE;

ABORTION; ALLELE; AMINO ACID SUBSTITUTION; ANIMAL CELL; ANIMAL TISSUE; ARTICLE; EPIDEMIC; EQUINE HERPES VIRUS; EQUINE HERPESVIRUS 1; GENOTYPE; HORSE DISEASE; INCIDENCE; NEUROLOGIC DISEASE; NONHUMAN; NUCLEOTIDE SEQUENCE; OPEN READING FRAME; PREVALENCE; VIRUS INFECTION; VIRUS STRAIN;

ABORTION, VETERINARY; ANIMALS; DNA, VIRAL; HERPESVIRUS 1, EQUID; HORSE DISEASES; HORSES; NERVOUS SYSTEM DISEASES; POLYMERASE CHAIN REACTION; PREVALENCE;

EQUID HERPESVIRUS 1; EQUIDAE; EQUINE HERPESVIRUS SP.;

EID: 75149120529     PISSN: 03781135     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vetmic.2009.07.030     Document Type: Article

References (36)

1. Allen G.P., O'Callaghan D.J., and Randall C.C. Genetic relatedness of equine herpesvirus types 1 and 3. J. Virol. 24 (1977) 761-767
2. Allen G.P., and Turtinen L.W. Assessment of the base sequence homology between the two subtypes of equine herpesvirus 1. J. Virol. 44 (1982) 249-255
3. Allen G.P., Kydd J.H., Slater J.D., and Smith K.C. Equid herpesvirus-1 (EHV-1) and -4 (EHV-4) infections. In: Coetzer J.A.W., and Tustin R.C. (Eds). Infectious Diseases of Livestock (2004), Cape Town, Oxford University Press, Southern Africa 829-859
4. Allen G.P. New insights into equine herpesvirus-1 (EHV-1) neurological disease. Equine Dis. Q. 15 1 (2006) 2-3
5. Allen G.P. Antemortem detection of latent infection with neuropathogenic strains of equine herpesvirus-1 in horses. Am. J. Vet. Res. 67 (2006) 1401-1405
6. Allen G.P. Development of a real-time polymerase chain reaction assay for rapid diagnosis of neuropathogenic strains of equine herpesvirus-1. J. Vet. Diagn. Invest. 19 (2007) 69-72
7. Allen G.P., and Timoney P.J. Recent advances in our understanding of equine herpesvirus-1 (EHV-1) myeloencephalopathy. 107th Annual Meeting of the United States Animal Health Association (2007) 373-380
8. Allen G.P., Bolin D.C., Bryant U., Carter C.N., Giles R.C., Harrison L.R., Hong C.B., Jackson C.B., Poonacha K., Wharton R., and Williams N.M. Prevalence of latent, neuropathogenic equine herpesvirus-1 in the Thoroughbred broodmare population of central Kentucky. Equine Vet. J. 40 (2008) 105-110
9. Anonymous, 2007. Equine herpesvirus myeloencephalopathy: a potentially emerging disease. In: USDA-APHIS (Eds.), APHIS Veterinary Services Center for Epidemiology and Animal Health, Washington, DC, USDA, pp. 40-43.
10. Bell S.A., Balasuriya U.B., Nordhausen R.W., and MacLachlan N.J. Isolation of equine herpesvirus-5 from blood mononuclear cells of a gelding. J. Vet. Diagn. Invest. 18 (2006) 472-475
11. Borchers K., Wolfinger U., Goltz M., Broll H., and Ludwig H. Distribution and relevance of equine herpesvirus type 2 (EHV-2) infections. Arch. Virol. 142 (1997) 917-928
12. Burki F., Rossmanith W., Nowotny N., Pallan C., Mostl K., and Lussy H. Viraemia and abortions are not prevented by two commercial equine herpesvirus-1 vaccines after experimental challenge of horses. Vet. Q. 12 (1990) 80-86
13. Burki F., Nowotny N., Oulehla J., Schmehlik O., Mostl K., Pallan C., and Rossmanith E. Attempts to immunoprotect adult horses, specifically pregnant mares, with commercial vaccines against clinical disease induced by equine herpesvirus-1. Zentralbl. Veterinarmed. B 38 (1991) 432-440
14. Burton E.A., Wechuck J.B., Wendell S.K., Goins W.F., Fink D.J., and Glorioso J.C. Multiple applications for replication-defective herpes simplex virus vectors. Stem Cells 19 (2001) 358-377
15. Chesters P.M., Allsop R., Purewal A., and Edington N. Detection of latency-associated transcripts of equid herpesvirus 1 in equine leukocytes but not in trigeminal ganglia. J. Virol. 71 (1997) 3437-3443
16. Clopper C.P.S. The use of confidence or fiducial limits illustrated in the case of the binomial. Biometrika 26 (1934) 404-413
17. Diallo I.S., Hewitson G.R., de Jong A., Kelly M.A., Wright D.J., Corney B.G., and Rodwell B.J. Equine herpesvirus infections in yearlings in South-East Queensland. Arch. Virol. 153 (2008) 1643-1649
18. Dynon K., Varrasso A., Ficorilli N., Holloway S., Reubel G., Li F., Hartley C., Studdert M., and Drummer H. Identification of equine herpesvirus 3 (equine coital exanthema virus), equine gammaherpesviruses 2 and 5, equine adenoviruses 1 and 2, equine arteritis virus and equine rhinitis A virus by polymerase chain reaction. Aust. Vet. J. 79 (2001) 695-702
19. Edington N., Welch H.M., and Griffiths L. The prevalence of latent equid herpesviruses in the tissues of 40 abattoir horses. Equine Vet. J. 26 (1994) 140-142
20. Frymus T., Kita J., Woyciechowska S., and Ganowicz M. Foetal and neonatal foal losses on equine herpesvirus type 1(EHV-1) infected farms before and after EHV-1 vaccination was introduced. Pol. Arch. Weter. 26 (1986) 7-14
21. Galosi C.M., de la Paz V.C., Fernandez L.C., Martinez J.P., Craig M.I., Barrandeguy M., and Etcheverrrigaray M.E. Isolation of equine herpesvirus-2 from the lung of an aborted fetus. J. Vet. Diagn. Invest. 17 (2005) 500-502
22. Goehring L.S., van Winden S.C., van Maanen C., and Sloet van Oldruitenborgh-Oosterbaan M.M. Equine herpesvirus type 1-associated myeloencephalopathy in the Netherlands: a four-year retrospective study (1999-2003). J. Vet. Inter. Med. 20 (2006) 601-607
23. Goodman L.B., Loregian A., Perkins G.A., Nugent J., Buckles E.L., Mercorelli B., Kydd J.H., Palu G., Smith K.C., Osterrieder N., and Davis-Poynter N. A point mutation in a herpesvirus polymerase determines neuropathogenicity. PLoS Pathog. 3 (2007) 1583-1592
24. Hastie T., and Tibshirani R. Monographs on statistics and applied probability #43. Generalized Additive Models (1990), Chapman and Hall/CRC, London pp. 95-101
25. Marenzoni M.L., Passamonti F., Cappelli K., Veronesi F., Capomaccio S., Supplizi A.V., Valente C., Autorino G., and Coletti M. Clinical, serological and molecular investigations of EHV-1 and EHV-4 in 15 unweaned thoroughbred foals. Vet. Rec. 162 (2008) 337-341
26. Nugent J., Birch-Machin I., Smith K.C., Mumford J.A., Swann Z., Newton J.R., Bowden R.J., Allen G.P., and Davis-Poynter N. Analysis of equid herpesvirus 1 strain variation reveals a point mutation of the DNA polymerase strongly associated with neuropathogenic versus nonneuropathogenic disease outbreaks. J. Virol. 80 (2006) 4047-4060
27. Patel J.R., and Heldens J. Equine herpesviruses 1 (EHV-1) and 4 (EHV-4)-epidemiology, disease and immunoprophylaxis: a brief review. Vet. J. 170 (2005) 14-23
28. Powell D. Equine herpesvirus abortions. Equine Dis. Q. 17 3 (2008) 4-5
29. Purewal A.S., Smallwood A.V., Kaushal A., Adegboye D., and Edington N. Identification and control of the cis-actinng elements of the immediate early gene of equid herpesvirus type 1. J. Gen. Virol. 73 (1992) 513-519
30. Pusterla N., Wilson W.D., Mapes S., Finno C., Isbell D., Arthur R.M., and Ferraro G.L. Characterization of viral loads, strain and state of equine herpesvirus-1 using real-time PCR in horses following natural exposure at a racetrack in California. Vet. J. 179 (2009) 230-239
31. Rosner B. Fundamentals of Biostatistics (2000), Duxbury Press, Pacific Grove, CA pp. 402-407, 430-434
32. Slater J.D., Borchers K., Thackray A.M., and Field H.J. The trigeminal ganglion is a location for equine herpesvirus 1 latency and reactivation in the horse. J. Gen. Virol. 75 Pt 8 (1994) 2007-2016
33. Slater J.D., Lunn D.P., Horohov D.W., Antczak D.F., Babiuk L., Breathnach C., Chang Y.W., Davis-Poynter N., Edington N., Ellis S., Foote C., Goehring L., Kohn C.W., Kydd J., Matsumura T., Minke J., Morley P., Mumford J., Neubauer T., O'Callaghan D., Osterrieder K., Reed S., Smith K., Townsend H., van der Meulen K., Whalley M., and Wilson W.D. Report of the equine herpesvirus-1 Havermeyer Workshop, San Gimignano, Tuscany, June 2004. Vet. Immunol. Immunopathol. 111 (2006) 3-13
34. Turtinen L.W., Allen G.P., Darlington R.W., and Bryans J.T. Serologic and molecular comparisons of several equine herpesvirus type 1 strains. Am. J. Vet. Res. 42 (1981) 2099-2104
35. Van de Walle G.R., Goupil R., Wishon C., Damiani A., Perkins G.A., and Osterrieder N. A single-nucleotide polymorphism in a herpesvirus DNA polymerase is sufficient to cause lethal neurological disease. J. Infect. Dis. 200 (2009) 20-25
36. Varrasso A., Dynon K., Ficorilli N., Hartley C.A., Studdert M.J., and Drummer H.E. Identification of equine herpesviruses 1 and 4 by polymerase chain reaction. Aust. Vet. J. 79 (2001) 563-569